 Austin Gillen
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyadenylation | 4 | 2022 | 38 | 1.770 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2019 | 288 | 1.620 |
Why?
| | Single-Cell Analysis | 6 | 2020 | 187 | 1.090 |
Why?
| | Hibernation | 2 | 2023 | 77 | 0.990 |
Why?
| | Torpor | 2 | 2023 | 15 | 0.940 |
Why?
| | Neoplastic Cells, Circulating | 2 | 2020 | 62 | 0.900 |
Why?
| | Transcriptome | 4 | 2021 | 756 | 0.710 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2445 | 0.690 |
Why?
| | Sequence Analysis, RNA | 7 | 2022 | 409 | 0.670 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2021 | 453 | 0.670 |
Why?
| | Ependymoma | 1 | 2020 | 169 | 0.650 |
Why?
| | Chromosomes, Artificial, Bacterial | 2 | 2019 | 20 | 0.650 |
Why?
| | Leukemia, Myeloid, Acute | 5 | 2023 | 532 | 0.630 |
Why?
| | Breast Neoplasms | 7 | 2020 | 1965 | 0.630 |
Why?
| | Transgenes | 2 | 2019 | 174 | 0.600 |
Why?
| | Gene Regulatory Networks | 2 | 2018 | 239 | 0.590 |
Why?
| | Immunoprecipitation | 2 | 2016 | 161 | 0.580 |
Why?
| | Carcinogenesis | 1 | 2017 | 182 | 0.550 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 254 | 0.540 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 226 | 0.530 |
Why?
| | 3' Untranslated Regions | 5 | 2022 | 142 | 0.530 |
Why?
| | Artifacts | 1 | 2016 | 125 | 0.530 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 371 | 0.530 |
Why?
| | Binding Sites | 2 | 2016 | 1224 | 0.460 |
Why?
| | MicroRNAs | 4 | 2016 | 637 | 0.450 |
Why?
| | Receptors, Estrogen | 5 | 2020 | 387 | 0.440 |
Why?
| | Gene Transfer Techniques | 1 | 2013 | 154 | 0.420 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 4 | 2022 | 165 | 0.410 |
Why?
| | RNA | 2 | 2023 | 833 | 0.400 |
Why?
| | Repressor Proteins | 2 | 2011 | 377 | 0.390 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2019 | 80 | 0.390 |
Why?
| | Cystic Fibrosis | 2 | 2018 | 964 | 0.380 |
Why?
| | Cell Differentiation | 4 | 2021 | 1753 | 0.360 |
Why?
| | Sulfonamides | 4 | 2022 | 445 | 0.350 |
Why?
| | Mammals | 2 | 2023 | 253 | 0.340 |
Why?
| | Homeodomain Proteins | 4 | 2021 | 468 | 0.320 |
Why?
| | Interferon-gamma | 1 | 2011 | 736 | 0.320 |
Why?
| | Transcription, Genetic | 2 | 2012 | 1323 | 0.290 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2018 | 1167 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 280 | 0.280 |
Why?
| | Gene Expression | 2 | 2023 | 1489 | 0.250 |
Why?
| | Animals | 18 | 2023 | 33381 | 0.250 |
Why?
| | Signal Transduction | 6 | 2020 | 4709 | 0.240 |
Why?
| | Humans | 34 | 2023 | 118974 | 0.240 |
Why?
| | Sciuridae | 2 | 2023 | 145 | 0.240 |
Why?
| | MCF-7 Cells | 3 | 2020 | 111 | 0.230 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2023 | 8 | 0.230 |
Why?
| | Protein Isoforms | 2 | 2022 | 345 | 0.230 |
Why?
| | RNA, Messenger | 5 | 2021 | 2657 | 0.230 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 15 | 0.230 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2021 | 143 | 0.220 |
Why?
| | Lymphatic Vessels | 2 | 2020 | 54 | 0.220 |
Why?
| | Lipoproteins, LDL | 2 | 2020 | 138 | 0.220 |
Why?
| | Estrogens | 4 | 2018 | 328 | 0.220 |
Why?
| | Azacitidine | 2 | 2022 | 119 | 0.210 |
Why?
| | Liver | 2 | 2020 | 1816 | 0.200 |
Why?
| | Mice | 13 | 2022 | 15520 | 0.200 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2021 | 63 | 0.200 |
Why?
| | Drosophila | 1 | 2022 | 140 | 0.200 |
Why?
| | Weight Gain | 2 | 2021 | 493 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 2 | 2020 | 509 | 0.190 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2020 | 7 | 0.190 |
Why?
| | Cells, Cultured | 6 | 2019 | 4077 | 0.180 |
Why?
| | rac GTP-Binding Proteins | 1 | 2020 | 36 | 0.180 |
Why?
| | Adipose Tissue | 2 | 2021 | 606 | 0.180 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 25 | 0.180 |
Why?
| | Neural Crest | 1 | 2021 | 117 | 0.180 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1346 | 0.180 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 178 | 0.180 |
Why?
| | Gene Library | 2 | 2019 | 127 | 0.180 |
Why?
| | Extracellular Fluid | 1 | 2019 | 32 | 0.180 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 65 | 0.180 |
Why?
| | Integrins | 1 | 2020 | 82 | 0.170 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 64 | 0.170 |
Why?
| | Neoplastic Stem Cells | 2 | 2023 | 336 | 0.170 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 175 | 0.170 |
Why?
| | Receptors, Progesterone | 2 | 2020 | 325 | 0.170 |
Why?
| | Neural Stem Cells | 1 | 2020 | 120 | 0.170 |
Why?
| | Promoter Regions, Genetic | 3 | 2013 | 1158 | 0.170 |
Why?
| | Hematopoiesis | 1 | 2020 | 175 | 0.170 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 176 | 0.170 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2020 | 99 | 0.170 |
Why?
| | Oligodendroglia | 1 | 2020 | 152 | 0.170 |
Why?
| | RNA Editing | 1 | 2018 | 22 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2021 | 252 | 0.160 |
Why?
| | Software | 2 | 2020 | 613 | 0.160 |
Why?
| | Motor Neurons | 1 | 2020 | 213 | 0.160 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 52 | 0.160 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 102 | 0.160 |
Why?
| | Bleomycin | 1 | 2019 | 228 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 671 | 0.160 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 544 | 0.160 |
Why?
| | Superoxide Dismutase | 1 | 2019 | 339 | 0.150 |
Why?
| | RNA Polymerase III | 1 | 2017 | 25 | 0.150 |
Why?
| | Regeneration | 1 | 2019 | 165 | 0.150 |
Why?
| | Zebrafish | 1 | 2021 | 434 | 0.150 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 151 | 0.150 |
Why?
| | Obesity | 2 | 2021 | 2746 | 0.150 |
Why?
| | Progestins | 1 | 2017 | 77 | 0.150 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2016 | 14 | 0.150 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1059 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2013 | 963 | 0.140 |
Why?
| | Bronchi | 1 | 2018 | 242 | 0.140 |
Why?
| | Epididymis | 2 | 2013 | 9 | 0.140 |
Why?
| | Lung Injury | 1 | 2019 | 210 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 359 | 0.140 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 462 | 0.140 |
Why?
| | Gene Expression Profiling | 6 | 2020 | 1597 | 0.140 |
Why?
| | Trachea | 1 | 2018 | 226 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1390 | 0.140 |
Why?
| | Hypoxia | 1 | 2022 | 963 | 0.140 |
Why?
| | Extracellular Matrix | 1 | 2019 | 446 | 0.140 |
Why?
| | Disease-Free Survival | 1 | 2017 | 649 | 0.140 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 68 | 0.130 |
Why?
| | Temperature | 1 | 2018 | 622 | 0.130 |
Why?
| | Apoptosis | 3 | 2019 | 2484 | 0.130 |
Why?
| | DNA Primers | 1 | 2016 | 533 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 755 | 0.130 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 576 | 0.130 |
Why?
| | Neoplasms | 2 | 2021 | 2179 | 0.130 |
Why?
| | CCCTC-Binding Factor | 2 | 2011 | 12 | 0.120 |
Why?
| | Chromosome Mapping | 2 | 2013 | 510 | 0.120 |
Why?
| | Tamoxifen | 3 | 2021 | 198 | 0.120 |
Why?
| | Spermatogenesis | 1 | 2013 | 53 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 982 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2019 | 732 | 0.120 |
Why?
| | Infertility, Male | 1 | 2013 | 61 | 0.120 |
Why?
| | Nucleosomes | 2 | 2013 | 131 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 2 | 2012 | 152 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 814 | 0.120 |
Why?
| | Down-Regulation | 1 | 2015 | 627 | 0.110 |
Why?
| | Cluster Analysis | 3 | 2022 | 481 | 0.110 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 93 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 195 | 0.110 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2013 | 310 | 0.110 |
Why?
| | Genetic Vectors | 1 | 2013 | 302 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 455 | 0.100 |
Why?
| | Genes, Regulator | 1 | 2011 | 33 | 0.100 |
Why?
| | Mitochondria | 1 | 2017 | 786 | 0.100 |
Why?
| | Caco-2 Cells | 1 | 2011 | 66 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1795 | 0.100 |
Why?
| | Luciferases | 1 | 2011 | 143 | 0.100 |
Why?
| | Tumor Microenvironment | 3 | 2020 | 454 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2025 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1794 | 0.100 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 84 | 0.100 |
Why?
| | Protein Binding | 1 | 2016 | 1975 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4908 | 0.090 |
Why?
| | Female | 11 | 2021 | 61565 | 0.090 |
Why?
| | Insulator Elements | 1 | 2009 | 2 | 0.090 |
Why?
| | 3' Flanking Region | 1 | 2009 | 6 | 0.090 |
Why?
| | Inflammation | 1 | 2019 | 2566 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 1194 | 0.080 |
Why?
| | CD146 Antigen | 2 | 2020 | 41 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 874 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2490 | 0.070 |
Why?
| | Chromatin | 1 | 2009 | 441 | 0.060 |
Why?
| | Disease Progression | 2 | 2023 | 2490 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2023 | 98 | 0.060 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 20 | 0.060 |
Why?
| | Male | 8 | 2022 | 57801 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 58 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 52 | 0.050 |
Why?
| | Thinness | 1 | 2021 | 91 | 0.050 |
Why?
| | Child | 1 | 2020 | 19129 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 34 | 0.050 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.050 |
Why?
| | Organogenesis | 1 | 2021 | 54 | 0.050 |
Why?
| | Head | 1 | 2021 | 89 | 0.050 |
Why?
| | Embryoid Bodies | 1 | 2020 | 8 | 0.050 |
Why?
| | Permeability | 1 | 2020 | 156 | 0.050 |
Why?
| | Morphogenesis | 1 | 2021 | 167 | 0.050 |
Why?
| | Colony-Forming Units Assay | 1 | 2020 | 93 | 0.050 |
Why?
| | Skull | 1 | 2021 | 127 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3730 | 0.050 |
Why?
| | Prognosis | 2 | 2020 | 3443 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 183 | 0.040 |
Why?
| | Tricarboxylic Acids | 1 | 2018 | 11 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 88 | 0.040 |
Why?
| | Ketoglutaric Acids | 1 | 2018 | 16 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 114 | 0.040 |
Why?
| | Mesoderm | 1 | 2020 | 141 | 0.040 |
Why?
| | Transcription Factors | 2 | 2021 | 1570 | 0.040 |
Why?
| | Gene Editing | 1 | 2019 | 63 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 331 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 247 | 0.040 |
Why?
| | Electron Transport Complex II | 1 | 2018 | 24 | 0.040 |
Why?
| | Succinate Dehydrogenase | 1 | 2018 | 44 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2019 | 268 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 462 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 155 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 42 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2020 | 443 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 289 | 0.040 |
Why?
| | Lung | 2 | 2022 | 3664 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 320 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 156 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 2851 | 0.040 |
Why?
| | Fatty Acids | 1 | 2020 | 407 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6561 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 226 | 0.040 |
Why?
| | Fibrosis | 1 | 2019 | 483 | 0.040 |
Why?
| | Amino Acids | 1 | 2020 | 465 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2020 | 359 | 0.040 |
Why?
| | Aged | 3 | 2020 | 19657 | 0.040 |
Why?
| | Mice, SCID | 1 | 2017 | 333 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2020 | 569 | 0.040 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 307 | 0.040 |
Why?
| | Stem Cells | 1 | 2020 | 559 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 574 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 65 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 870 | 0.030 |
Why?
| | Fibroblasts | 1 | 2020 | 842 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1324 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 740 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2018 | 454 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 2014 | 54 | 0.030 |
Why?
| | Expert Systems | 1 | 2013 | 3 | 0.030 |
Why?
| | DNA, Intergenic | 1 | 2013 | 25 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2014 | 258 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 767 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1636 | 0.030 |
Why?
| | Organ Specificity | 1 | 2013 | 278 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2680 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 460 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2062 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 770 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2011 | 219 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1153 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5392 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2275 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 588 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3588 | 0.020 |
Why?
| | Fetus | 1 | 2013 | 690 | 0.020 |
Why?
| | DNA Footprinting | 1 | 2009 | 28 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 36 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 9342 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2159 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 1323 | 0.020 |
Why?
| | Adult | 2 | 2019 | 31512 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2674 | 0.020 |
Why?
| | Middle Aged | 1 | 2019 | 27617 | 0.010 |
Why?
|
|
Gillen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|